Exact Sciences Corporation (EXAS)
NASDAQ: EXAS · IEX Real-Time Price · USD
43.17
+0.74 (1.74%)
Jul 2, 2024, 4:00 PM EDT - Market closed

Exact Sciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year
20232022202120202019 2018 - 1997
Net Income
-204.15-623.51-595.63-823.61-213.09
Upgrade
Depreciation & Amortization
234.5226.2206.17179.0855.67
Upgrade
Share-Based Compensation
231.31206.82334.02152.91108.48
Upgrade
Other Operating Activities
-105.54-33.07-46.81628.1-62.72
Upgrade
Operating Cash Flow
156.12-223.56-102.24136.48-111.66
Upgrade
Capital Expenditures
-124.19-189.46-135.77-65.08-172.65
Upgrade
Acquisitions
-52.91-14.69-557.8-434.03-973.86
Upgrade
Change in Investments
226.53278.76-387.77-203.281,023
Upgrade
Other Investing Activities
0.25-0.55-0.740.35-1
Upgrade
Investing Cash Flow
49.6874.07-1,082.09-702.04-124.43
Upgrade
Share Issuance / Repurchase
31.5432.0237.51907.1317.18
Upgrade
Debt Issued / Paid
137.9850-23.75974.24236.12
Upgrade
Other Financing Activities
-9.75-5.53-5.29-1.76-0.12
Upgrade
Financing Cash Flow
159.7776.498.471,880253.18
Upgrade
Exchange Rate Effect
1.320.030.0200
Upgrade
Net Cash Flow
366.89-72.98-1,175.831,31417.1
Upgrade
Free Cash Flow
31.93-413.02-23871.4-284.31
Upgrade
Free Cash Flow Margin
1.28%-19.82%-13.47%4.79%-32.44%
Upgrade
Free Cash Flow Per Share
0.18-2.34-1.390.47-2.17
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).